// App-Quantinova.ai

188.0 : Integrative molecular profiling and response to chemotherapy on the COMPASS trial.

Researchers

Presenter

  • Grainne M. O'Kane

Principal Investigators

  • Sandra Fischer

  • Rob Denroche

  • Gun Ho Jang

  • Amy Zhang

  • Anna Dodd

  • Robert C Grant

  • Barbara Grunwald

  • Mehdi M Masoomian

  • Shari Moura

  • Elena Elimova

  • Rebecca M. Prince

  • George Zogopoulos

  • Faiyaz Notta

  • Julie Wilson

  • Steven Gallinger

  • Jennifer J. Knox

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Ontario Institute for Cancer Research, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • McGill University Health Centre, Montreal, QC, Canada

  • Toronto Western Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • NCT02750657

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved